0001382963-17-000128.txt : 20170810 0001382963-17-000128.hdr.sgml : 20170810 20170810142520 ACCESSION NUMBER: 0001382963-17-000128 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170810 DATE AS OF CHANGE: 20170810 EFFECTIVENESS DATE: 20170810 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioQ Pharma Inc CENTRAL INDEX KEY: 0001278320 IRS NUMBER: 000000000 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-292569 FILM NUMBER: 171020973 BUSINESS ADDRESS: STREET 1: 185 BERRY STREET STREET 2: SUITE 160 CITY: SAN FRANCISCO STATE: CA ZIP: 94107 BUSINESS PHONE: 4159750805 MAIL ADDRESS: STREET 1: 185 BERRY STREET STREET 2: SUITE 160 CITY: SAN FRANCISCO STATE: CA ZIP: 94107 FORMER COMPANY: FORMER CONFORMED NAME: BIOQUIDDITY INC DATE OF NAME CHANGE: 20040202 D 1 primary_doc.xml X0708 D LIVE 0001278320 BioQ Pharma Inc 185 BERRY STREET SUITE 160 SAN FRANCISCO CA CALIFORNIA 94107 4159750805 CALIFORNIA BIOQUIDDITY INC Corporation true Joshua W. Kriesel 185 Berry Street, Suite 160 San Francisco CA CALIFORNIA 94107 Executive Officer Director Ron Pauli 185 Berry Street, Suite 160 San Francisco CA CALIFORNIA 94107 Executive Officer Norvall William Jasper, Jr. 185 Berry Street, Suite 160 San Francisco CA CALIFORNIA 94107 Director Mark J. Ehlert 185 Berry Street, Suite 160 San Francisco CA CALIFORNIA 94107 Director Richard Nesbit 185 Berry Street, Suite 160 San Francisco CA CALIFORNIA 94107 Director Llew Keltner 185 Berry Street, Suite 160 San Francisco CA CALIFORNIA 94107 Director Christopher Portman 185 Berry Street, Suite 160 San Francisco CA CALIFORNIA 94107 Director Daniel Tasse 185 Berry Street, Suite 160 San Francisco CA CALIFORNIA 94107 Director Pharmaceuticals Decline to Disclose 06b false 2017-08-09 false true true false 0 6250000 6250000 0 false 2 0 0 0 false BioQ Pharma Inc /S/JOSHUA W. KRIESEL JOSHUA W. KRIESEL CHIEF EXECUTIVE OFFICER AND PRESIDENT 2017-08-09